PE120399A1 - COMPOSITIONS INHIBITING OSEA RESORPTION - Google Patents
COMPOSITIONS INHIBITING OSEA RESORPTIONInfo
- Publication number
- PE120399A1 PE120399A1 PE00089498A PE00089498A PE120399A1 PE 120399 A1 PE120399 A1 PE 120399A1 PE 00089498 A PE00089498 A PE 00089498A PE 00089498 A PE00089498 A PE 00089498A PE 120399 A1 PE120399 A1 PE 120399A1
- Authority
- PE
- Peru
- Prior art keywords
- zoledronate
- resorption
- osea
- composition
- compositions inhibiting
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
CARACTERIZADA PORQUE COMPRENDE UN BISFOSFONATO TAL COMO ALENDRONATO MONOSODICO TRIHIDRATO, CIMADRONATO, CLODRONATO, TILUDRONATO, ETIDRONATO, IBANDRONATO, RISEDRONATO, PIRIDRONATO, PAMIDRONATO, ZOLEDRONATO, UTILIZANDOSE DE 8,75 mg A 140 mg. TAMBIEN SE REFIERE A UNA COMPOSICION QUE COMPRENDE ADEMAS a)UN BLOQUEADOR DE RECEPTORES DE HISTAMINA H2 O UN INHIBIDOR DE LA BOMBA DE PROTONES TAL COMO CIMETIDINA, FAMOTIDINA, NIZATIDINA, RANITIDINA, OMEPRAZOL, LANSOPRAZOL; b)SUPLEMENTO DE CALCIO. LA COMPOSICION INHIBE LA RESORCION OSEA, POR LO QUE PUEDE SER UTIL PARA TRATAR O PREVENIR LA OSTEOPOROSIS. EL USO DE LA COMPOSICION MINIMIZA LA OCURRENCIA POTENCIAL DE EFECTOS GASTROINTESTINALES ADVERSOSCHARACTERIZED BECAUSE IT INCLUDES A BISPHOSPHONATE SUCH AS MONOSODIUM ALENDRONATE TRIHYDRATE, CYMADRONATE, CLODRONATE, TILUDRONATE, ETIDRONATE, IBANDRONATE, RISEDRONATE, PIRIDRONATE, 8, ZOLEDRONATE, ZOLEDRONATE, ZOLEDRONATE, ZOLEDRONATE, ZOLEDRONATE, ZOLEDRONATE, ZOLEDRONATE, ZOLEDRONATE, ZOLEDRONATE, ZOLEDRONATE, ZOLEDRONATE, ZOLYDRONATE IT ALSO REFERS TO A COMPOSITION FURTHER COMPRISING a) A HISTAMINE H2 RECEPTOR BLOCKER OR A PROTON PUMP INHIBITOR SUCH AS CIMETIDINE, NIZATIDINE, RANITIDINE, OMEPRAZOLE, LANSOPRAZOL; b) CALCIUM SUPPLEMENT. THE COMPOSITION INHIBITS BONE RESORPTION, SO IT MAY BE USEFUL TO TREAT OR PREVENT OSTEOPOROSIS. THE USE OF COMPOSITION MINIMIZES THE POTENTIAL OCCURRENCE OF ADVERSE GASTROINTESTINAL EFFECTS
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PE00089498A PE120399A1 (en) | 1998-09-18 | 1998-09-18 | COMPOSITIONS INHIBITING OSEA RESORPTION |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PE00089498A PE120399A1 (en) | 1998-09-18 | 1998-09-18 | COMPOSITIONS INHIBITING OSEA RESORPTION |
Publications (1)
Publication Number | Publication Date |
---|---|
PE120399A1 true PE120399A1 (en) | 2000-01-18 |
Family
ID=46799393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE00089498A PE120399A1 (en) | 1998-09-18 | 1998-09-18 | COMPOSITIONS INHIBITING OSEA RESORPTION |
Country Status (1)
Country | Link |
---|---|
PE (1) | PE120399A1 (en) |
-
1998
- 1998-09-18 PE PE00089498A patent/PE120399A1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU91364I2 (en) | Sodium alendronate / colecalciferol | |
NZ545804A (en) | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-or-vitamin D derivatives and a bisphosphonate | |
JP2002529490A5 (en) | ||
DK1296689T3 (en) | Process for administration of bisphosphonates | |
NZ272608A (en) | Inhibiting bone loss by administering a bisphosphonate and a second compound selected from various compounds, including 2-phenyl-3-aroylbenzothienes; bisphosphonate combination salts | |
DE69905488T2 (en) | PROSTAGLANDIN CONJUGATES FOR TREATING BONE DISEASES | |
JP2005530819A5 (en) | ||
PE120399A1 (en) | COMPOSITIONS INHIBITING OSEA RESORPTION | |
Widler et al. | Amino-substituted GEM-bisphosphonates | |
YU1800A (en) | Use of a bisphosphonate for production drug for a bone resorption inhibiting |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
MC | Annulment |